221 related articles for article (PubMed ID: 2646313)
1. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia.
Ron D; Powers AC; Pandian MR; Godine JE; Axelrod L
J Clin Endocrinol Metab; 1989 Apr; 68(4):701-6. PubMed ID: 2646313
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.
Daughaday WH; Emanuele MA; Brooks MH; Barbato AL; Kapadia M; Rotwein P
N Engl J Med; 1988 Dec; 319(22):1434-40. PubMed ID: 3185662
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
Nauck MA; Reinecke M; Perren A; Frystyk J; Berishvili G; Zwimpfer C; Figge AM; Flyvbjerg A; Lankisch PG; Blum WF; Klöppel G; Schmiegel W; Zapf J
J Clin Endocrinol Metab; 2007 May; 92(5):1600-5. PubMed ID: 17299065
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid.
Lowe WL; Roberts CT; LeRoith D; Rojeski MT; Merimee TJ; Fui ST; Keen H; Arnold D; Mersey J; Gluzman S
J Clin Endocrinol Metab; 1989 Dec; 69(6):1153-9. PubMed ID: 2584352
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
Tally M; Eriksson U; Thorén M; Brismar K; Hall K
J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
[TBL] [Abstract][Full Text] [Related]
6. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
7. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
[TBL] [Abstract][Full Text] [Related]
9. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.
Shapiro ET; Bell GI; Polonsky KS; Rubenstein AH; Kew MC; Tager HS
J Clin Invest; 1990 May; 85(5):1672-9. PubMed ID: 2159026
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
Chung J; Henry RR
J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
[TBL] [Abstract][Full Text] [Related]
11. Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces fasting hypoglycemia.
Herrmann BL; Saller B; Kiess W; Morgenroth K; Drochner K; Schröder T; Mann K
Exp Clin Endocrinol Diabetes; 2000; 108(8):515-8. PubMed ID: 11149628
[TBL] [Abstract][Full Text] [Related]
12. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
Bach MA; Chin E; Bondy CA
J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
[TBL] [Abstract][Full Text] [Related]
13. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.
Zapf J; Schmid C; Guler HP; Waldvogel M; Hauri C; Futo E; Hossenlopp P; Binoux M; Froesch ER
J Clin Invest; 1990 Sep; 86(3):952-61. PubMed ID: 1697608
[TBL] [Abstract][Full Text] [Related]
14. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia.
Daughaday WH; Trivedi B; Kapadia M
J Clin Endocrinol Metab; 1981 Aug; 53(2):289-94. PubMed ID: 7019228
[TBL] [Abstract][Full Text] [Related]
15. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
17. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
18. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia Observed on Continuous Glucose Monitoring Associated With IGF-2-Producing Solitary Fibrous Tumor.
Otake S; Kikkawa T; Takizawa M; Oya J; Hanai K; Tanaka N; Miura J; Fukuda I; Kanzaki M; Sawada T; Hizuka N; Onuki T; Uchigata Y
J Clin Endocrinol Metab; 2015 Jul; 100(7):2519-24. PubMed ID: 25915566
[TBL] [Abstract][Full Text] [Related]
20. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
Zapf J; Futo E; Peter M; Froesch ER
J Clin Invest; 1992 Dec; 90(6):2574-84. PubMed ID: 1281841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
